T

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Watchlist Manager
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Watchlist
Price: 8.51 CNY 0.71% Market Closed
Market Cap: 16.7B CNY

Intrinsic Value

The intrinsic value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is 10.35 CNY. Compared to the current market price of 8.51 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is Undervalued by 18%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
10.35 CNY
Undervaluation 18%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation History
Tonghua Dongbao Pharmaceutical Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Tonghua Dongbao Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Tonghua Dongbao Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Tonghua Dongbao Pharmaceutical Co Ltd.

Explain Valuation
Compare Tonghua Dongbao Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Tonghua Dongbao Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tonghua Dongbao Pharmaceutical Co Ltd

Current Assets 2.5B
Cash & Short-Term Investments 1.2B
Receivables 484m
Other Current Assets 812.2m
Non-Current Assets 5.4B
Long-Term Investments 780m
PP&E 2.7B
Intangibles 1.6B
Other Non-Current Assets 283m
Current Liabilities 1.4B
Accounts Payable 85m
Accrued Liabilities 12m
Short-Term Debt 605m
Other Current Liabilities 700m
Non-Current Liabilities 324m
Long-Term Debt 266m
Other Non-Current Liabilities 58m
Efficiency

Free Cash Flow Analysis
Tonghua Dongbao Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tonghua Dongbao Pharmaceutical Co Ltd

Revenue
2.6B CNY
Cost of Revenue
-732.4m CNY
Gross Profit
1.9B CNY
Operating Expenses
-1.6B CNY
Operating Income
332.6m CNY
Other Expenses
72.9m CNY
Net Income
405.5m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tonghua Dongbao Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Sustainable 3Y Average Net Margin
50/100
Profitability
Score

Tonghua Dongbao Pharmaceutical Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tonghua Dongbao Pharmaceutical Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
80/100
Solvency
Score

Tonghua Dongbao Pharmaceutical Co Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tonghua Dongbao Pharmaceutical Co Ltd

Wall Street analysts forecast Tonghua Dongbao Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 11.38 CNY with a low forecast of 9.9 CNY and a high forecast of 14.7 CNY.

Lowest
Price Target
9.9 CNY
16% Upside
Average
Price Target
11.38 CNY
34% Upside
Highest
Price Target
14.7 CNY
73% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tonghua Dongbao Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Tonghua Dongbao Pharmaceutical Co Ltd stock?

The intrinsic value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is 10.35 CNY.

Is Tonghua Dongbao Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8.51 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is Undervalued by 18%.

Back to Top